Abstract: Aflatoxicosis mostly leads to serious clinical signs of malnutrition, growth retardation, and impairment of utilization of nutrients, immunosupression, liver diseases and cancer. Detoxification or prevention of such toxicity is interesting to researchers in change field. In pursuit for an approach, the synthetic copper(I)-nicotinate complex has been evaluated against the traditional Butylated hydroxy toluene (BHT) for possible protective effects as a food additive in induced aflatoxicosed animals. Induction of toxicity in adult rats by AFB 1 60 µg/kg body weight divided on three times a week for consecutive five weeks resulted in marked hepatic necrosis, collagen fibers around portal tract and iron deposits as well as features of general cellular collapse and cirrhosis. The protective effects were tested on two animal groups by associate doses of BHT (0.05 mg / kg B.W.) in one group and copper (I) nicotinate complex (0.4 mg/kg B.W.) in the other. Results showed, in both groups, almost normal histological as well as biochemical markers especially those treated with the copper complex, which suggests that anti-inflammatory copper complex can be used as a protective agent against aflatoxicosis when used in doses resemble those used in pharmaceutical vitamin supplements.
INTRODUCTION
Biological mycotoxicosis depends mainly on the type of mycotoxin [1] , as the acute or chronic intoxication by AFB 1 is reflected according to the level of metabolite 8,9-epoxide [2] . The bioactivation product, epoxide, is the most known genotoxic product of AFB 1 [3] . Proteins that bind with aflatoxin B 1 or its metabolites act as reservoir that sustains exposure for aflatoxicosis [4] [5] [6] . Evidence has been accumulating regarding the development of human hepatocellular carcinoma HCC with respect to AFB 1 -epoxide where the P53 tumor suppressor gene and more specifically, codon 249 of this gene were seriously affected [7] . Butylated hydroxy toluene is one of the most known food additives antioxidant that showed a versatile chemoprotective agent against mammary and liver cancer induced by several carcinogenic chemicals including AFB 1 [8] [9] [10] . In mammals, the most important mechanism of AFB 1 -epoxide detoxification is attributed to the high affinity of glutathione-S-tranferase towards the more potent exo-epoxide derivation [11] . Such an affinity is proven to be promoted by the antioxidant butylated hydroxy derivatives [12, 13] . Generally, antioxidants may impact their anti-carcinogenic property by inducing cellular detoxification pathway [14, *Address correspondence to this author at the Al-Azhar University, Assiut Branch, Faculty of Science, Chemistry Department, Egypt; Tel: 00201006785228; E-mail : ahmedshatat82@yahoo.com 15] . With regard to many of the biologically active copper chelating complexes [16] was the copper (I)-nicotinate that exhibiting antioxidant activity as well as therapeutic pharmaceutical activity against Newcastle diseases [17] , anti-inflammatory effect on gastric ulcer [18] , reduction of adverse effects of 5-Fluorouracil in patients with hepatocelluler carcinoma [19] and curative effect against induction of fatty liver in experimental animals [20] .
AIM OF THE WORK
This work has been designed in order to evaluate the prophylactic effect of a bioactive copper (I) nicotinate complex as a food additive against aflotoxicosis. For this purpose the complex was given within the daily requirement of copper element, versus a commercially used phenolic derivative BHT.
MATERIALS AND METHODS
Fifty five Wister albino male rats (120-150 g B.W.) were accommodated in appropriate healthy conditions and grouped into 4 groups: group I contained 15 animals for control measurements G I , and 3 groups; 15 animals each, for experiment. The experimental groups were aflatoxicosed by orally ingested AFB 1 (60 µg/kg B.W.), three times weakly for consecutive five weeks. The toxin as a pure sample was a gift from the Department of Botany, Mycology Center, Faculty of Science, Assiut University, Egypt. The First experimental group aflatoxicosed received no associate treatment; experimental control G II . The second experimental group G III animals were supplemented by BHT (0.05 g/kg B.W.) concomitant with AFB 1 [21] . The phenolic BHT was purchased from Oxford Laboratory -Mumbai-400002, CAS No. (128-73-0). The third experimental group G IV were treated by the synthesized copper(I)-nicotinate complex (400 µg/kg B.W.) concomitant with AFB 1 [22] . Experimental groups were scarified at the end of the time course of the experiment (5 weeks). Blood serum and liver tissue samples were collected for chemical analysis and histopathological examination. The tested biochemical parameters on the liver tissue were performed on homogenates (one gm/9 ml phosphate buffer at pH 7.4).
The biochemical testes included total protein [23] , amino transferases ALT and AST (diagnostic kit by spectrum diagnostics, Egyptian company for biotechnology S.A.E.), nitric oxide [24] , total thiols [25] , superoxide dismutase [26] , reduced glutathione [27] , glutathione peroxidase [28] , glutathione-S-tranferase [29] , serum ceruloplasmine [30] and lipid peroxide [31] . Histological examination including iron staining was done by Perls' Prussian blue reaction according to Wang and Liao (2003) [32] [34] .
RESULTS
Serum total protein (g/dl): Table 1 , shows: the animals in G II showed dramatic reduction in serum total proteins that was highly significantly reduced vs normal control animals in G I (p<0.001). Intoxicated animals co-treated with BHT in G III showed that was non-significantly higher than normal. Similarly intoxicated animals co-treated with Cu-nicotinate complex in G IV showed also non-significantly higher than normal control. Serum albumin level (g/dL): Table 1 shows the aflatoxicosed animals G II that was significantly lower than normal (p<0.001). Aflatoxicosed animals co-treated with BHT in G III showed non-significantly lower than normal controls. Similarly intoxicated animals co-treated with Cu-nicotinate complex in G IV showed also non-significantly lower than normal controls. Serum ALT activity (U/L): Table 1 , showed dramatic increased in G II than normal, (p<0.001). The level of serum ALT increased in G III which was still significant (p<0.05). Aflatoxicosed animals of G IV was non-significantly than normal (p<0.05). Serum AST activity (U/L): Table 1 shows the aflatoxicosed animals in G II, that was dramatically significant increased over normal, (p<0.001). AST level of G III it was still significantly higher than normal but is much less than control. The G IV group showed a reduced level of AST but it was still significantly higher than normal, (p<0.05). Serum total thiols concentration (nmol/ml): Table 1 illustrates the G II that was significantly reduced from normal control, (p<0.001). The GIII that was still lower significantly than normal control, (p<0.001). Similarly G IV showed a level of total thiols that was significantly lower than normal control, (p<0.05). Serum and hepatic tissue GSH (nmol/ml), (nmol/mg protein): from Table 1 , G II showed prominent reduction in serum GSH value that was highly significantly reduced than normal, (p<0.001). Animals co-treated with BHT G III showed also reduction that was statistically not different from normal. Similarly G IV showed the same response that was also nonsignificantly deviated from normal value. In the hepatic tissue Table 2 , G II animals showed significant reduction in hepatic tissue GSH value from normal,(p<0.001). Animals co-treated with BHT G III showed slightly reduction in the level GSH from the normal. While G IV animals showed also nonsignificantly different level from normal, (p<0.05). Total thiols of hepatic tissue (nmol/g): From Table 2 , Aflatoxicosed untreated animals, G II, showed significant reduction from normal animals (p<0.001). The co-treated BHT animals in G III that was significantly lower than normal, but was about three times the value in untreated G II . Similarly G IV showed improvement in hepatic tissue total thiols that was nonsignificantly different from normal, (p<0.001). Hepatic tissue lipid peroxidation level (nmol/g): from Table 2 , it was found that significantly increased over normal in GII, (p<0.001). This level in GIII group was significantly elevated than normal (p<0.05). GIV didn't show any significant elevation over normal; (p<0.001). Serum nitric oxide concentrations (µmol/ml): in Table 1 , The G II showed dramatically significant increase higher than normal, (p<0.001). The level of serum nitric oxide concentration was non-significantly changed from normal in G III animals, (p<0.001). The G IV showed also non-significant lower value, (p<0.001). Hepatic tissue nitric oxide concentrations (µmol/g proteins): from Table 2 , The G II liver NO was significantly elevated than normal (p<0.01), While G III was non-significantly higher than normal value (p<0.001). Similarly, the animals co-treated with Cu-nicotinate complex; G IV changed to significant lower value. Serum superoxide dismutase (SOD) activity (U/ml): From Table 1 , the aflatoxicosed untreated rats GII showed significant lower than normal (p<0.01). The level of serum SOD was increased in GIII non-significantly higher than (p>0.001). Aflatoxicosed animals with simultaneously cotreatment with Cu-nicotinate complex GIV showed significantly higher than normal (p<0.001). Hepatic tissue glutathione peroxidase GsPx activity as (nmol/min/mg protein): From Table 2 , it was found that the level of hepatic tissue GsPx was significantly lower than normal (p<0.001). GIII group exhibited improvement response that was significantly greater than normal (p<0.05). GIV showed signs of improvement which was non-significantly different from normal. Serum glutathione-S-transferase (GST) concentrations (nmol/min/ml): Table 1 : GII aflatoxicosed without treatment showed remarkable reduction in serum GST value that was significantly different from normal (p<0.001). GIII group showed more or less reduced level from the normal, that change was significant (p<0.05). GIV showed improvement that was non-significant change from normal (p<0.001).
Hepatic tissue GST concentration (nmol/min/mg protein): it is seen from Table 2 , G II that was a significant reduction in the enzyme activity than normal (p<0.001). G III measurement showed improvement that was a significant change from normal (p<0.05). G IV animals measurement reflected great improvement that was non-significantly different from normal (p<0.01). Serum ceruloplasmine (mg/dl): Table 1 illustrates the level was dramatically reduction in G II that was a significant reduction from normal (p<0.001). G III animals value that was non-significantly different from normal (p<0.05). The G IV group exceeded the normal level to significantly greater value (p<0.01).
Histological Examination: Fig. (1) shows histological features of health control G I animals. Fig. (2a through e) shows microscopic examination of aflatoxicosed livers of G II animals. The liver appeared with markedly dilated congested central vein occupied by large thrombus and multiple iron deposits as well as hepatic cellular necrosis (Fig 2a) . as mononuclear inflammatory cells formed mainly of lymphocytes, the portal tracts appear thickened by cell proliferation of bile ducts as well as mononuclear inflammatory cells formed mainly of lymphocytes, Fig. (2e) . Fig. (3a) , shows liver section of G III animals; perivascular infiltration of the hepatic parenchyma with lymphocytes (star), some hepatocytes exhibit vesicular nuclei others appear with dense nuclei, in Fig. (3b) of the same group, we find minimal cellular infiltration in the portal tract area, multiple small bile ducts are present, hepatocytes have more or less normal appearance. In Fig. (3c) , of G IV group, remarkable modulation in the effect of AFB 1 on the liver where hepatic architecture returned to normal appearance. Fig. (5d) , G IV liver section showed no signs of iron deposits in the central vein or liver parenchyma. Fig. (3a) , shows liver section of G III animals; perivascular infiltration of the hepatic parenchyma with lymphocytes (star), some hepatocytes exhibit vesicular nuclei others appear with dense nuclei, in Fig. (3b) of the same group, we find minimal cellular infiltration in the portal tract area, multiple small bile ducts are present, hepatocytes have more or less normal appearance. In Fig. (3c) , of G IV group, remarkable modulation in the effect of AFB 1 on the liver where hepatic architecture returned to normal appearance. see Fig. (4c) . while in Fig. (5d) , G IV liver section showed no signs of iron deposits in the central vein or liver parenchyma.
DISCUSSION
The assayed biochemical parameters in circulating systemic blood as well as hepatic tissue homogenates were in consistency with those findings of the microscopic examination characters. The total serum protein or serum albumin levels were highly reduced by aflatoxicosis due to inhibition of protein synthesis in hepatic tissue and other organs [35, 36] . The antioxidant BHT prevented such reduction in protein synthesis due to chemoprevention of aflatoxin B 1 metabolism in biological systems [37] . Similarly, treatment with copper nicotinate complex showed improvement that confers a hepato-cellular protective as well as antioxidant effect of copper (I) nicotinate complex [18] [19] . Concomitantly, the changes in transaminases gave a positive sign for the protective effect of either BHT or the copper (I)-nicotinate complex against hepatic tissue collapse by aflatoxicosis. Elevated levels of measured hepatocellular oxidative stress markers (NO and lipid peroxide) were prominent by aflatoxicosis [38] . Co-treatment by either BHT or copper nicotinate complex that reduced such biochemical parameters indicates that both of them are real able hepatocellular protective agent.
Reduction of accumulated levels NO and lipid peroxides in hepatic tissue by BHT and the copper complex cotreatment that was regulated and promoted by elevation of antioxidant cellular chemicals such as GSH and total thiols [39] , this could be attributed frankly to the antioxidant effect of BHT [20, 40] and the cellular protective antioxidant Cu(I)-nicotinate complex [41] . Since, induction of protective GST has been posited possible chemoprotective mechanism by BHT and other phenolic antioxidant as enzyme promoters has been confirmed before by Hayes et al., (1996) [42] . Herein, results could be rationally accepted. Inasmuch as parallel enzymatic induction for the GSTmediated detoxificating enzyme against AFB1 by using the copper (I)-nicotinate complex, in this study is the first time to be deduced. The blood circulating levels of such parameters that were parallel to those of hepatic tissue could be interpreted similarly due to the antioxidant character of BHT and the predicted cellular protectant anti-inflammatory and antioxidant effect of the Cu(I)-nicotinate complex on the cellular levels.
Since, aflatoxicosis is among the widely encountered features of environmental pollution that deteriorates the hepatic tissue; induction of aflatoxicosis in the tested experimental animals was associated with cellular damage that was characterized by, focal hepatic necrosis and increased collagen fibers around central vein and portal tract as it was detected by microscope. These characters were mostly absent by co-treatment with BHT. These findings are simply accepted due to pervious success of the use of BHT in preventing aflatoxicosis [43] . In addition, these cellular improving characters were microscopically obvious by utilization of the copper complex under consideration as a protective agent. This improvement was predicted since this complex has been confirmed previously as a therapeutic agent against induced non-alcoholic fatty liver in experimental animals [20] .
Herein, after ingestion, AFB1 might be converted into its epoxide or the epoxide of its major metabolites AFM1 and these derivatives produced DNA adducts causing DNA strand breaks and point mutations [44] . Under this pathological condition, the active process of cellular self destruction, apoptosis may occur. The MDA is the end product of lipoperoxydation, considered as a late biomarker of oxidative stress and cellular damage [45, 46] . Hence, the aflatoxicosed animals that were characterized by a marked increase in MDA level in the liver (Table 2) , the oxidative damage is considered to be the main mechanism leading to the subsequent hepatotoxicity as it was reported before [47] . Protective activity of the antioxidant Thymoquinone (TQ) also was evaluated in a similar study against liver toxicity induced by AFB1 in mice. The serum levels of hepatic enzymes primarily reflect the degree of liver damage and have been commonly used as a diagnostic marker for hepatotoxicity. As shown in Table 1 , AFB1 significantly elevated, AST and ALT which is in agreement with results of other studies [48, 49] . This finding is consistent within histopathological examination in which necrosis and degeneration, hyperplasia of kupffer cells and infiltration of mononuclear cells in liver sections that were observed. BHT prevented the histopathological changes as well as those co-treated by the copper complex decreased the number of inflammatory cells that was in parallel to the biochemical findings. However cotreatment with the copper (I) nicotinate complex initiated complete amelioration of the AFB1 associated changes where the liver tissues looked more or less similar to those of control. Markedly increase in the collagen fibers around portal tract in aflatoxin intoxicated animals in the present study are similar to those previously described for aflatoxicosis [50, 51] especially that was published by Bastianello et al., (1987) [50] who described the pathology of acute, subacute, and chronic aflatoxicosis. In this review the subacute form was typically characterized by extensive bile ductule hyperplasia with varying degrees of fibrosis and bridging fibrosis [50, 52, 53] . Typically, the chronic form was also characterized by extensive fibroplasia. Additionally, observed severe bile ductule proliferation and visible regenerative hepatocellular nodules could be frankly defined [50] as it was reported. BHT cotreated animals in this study exhibited reduced collagen fibers around portal tract, while animals co-treated by copper(I)-nicotinate complex exhibited amelioration in the effect of AFB1 on the liver with complete reduction in the collagen fibers around portal tract in comparison to those treated with BHT group. The current study shows that, induced aflatoxicosis dramatically reduced the level of the main blood circulating enzymatic free radical scavenger SOD, which was previously confirmed by others [54, 55] . Such a reduction was elevated and normalized by the antioxidant co-treating agents BHT or the copper nicotinate complex. Notably, the copper complex was significantly more potent than that of the co-treating BHT. This prominent observation could be attributed to the biochemical behavior of the copper complexes that was confirmed to be similar to the SOD activities such as Cu(II)(3,5-diisopropylsalicylic acid)2 (CuDIPS) [56] , Cu(II) histidine complexes [57] , Cu(II) complexes of macrocyclic polyamine derivatives [58] , Bis(2,9-dimethyl-1,10-phenaanthroline)-Cu(I)nitrate (Cu(I) (DMP)2) [59] and Cu(II)-oligopeptide [60] .
Similarly, the blood ceruloplasmin that was highly consumed by aflatoxicosis was improved by association of the co-treatment of the anti-inflammatory agents BHT or the tested copper-nicotinate complex. The latter was also highly significantly more effective than that of the BHT. It is worthy noted that ceruloplasmine is one of the acute phase transport proteins and that after intoxication; copper and zinc are depleted and tend to leave the body with urine, this depletion of copper may be a causative parameter for the decrease of ceruloplasmine [61] .
CONCLUSION
Basically, these obtained results by using cpper (I)-nicotinate complex as a profelactive therapeutic agent against aflatoxicosis not only acts like BHT but also it was more prominently effective on measured parameters and biologically saver as food additive than the synthetic BHT.
CONFLICT OF INTEREST
The authors confirm that this article content has no conflicts of interest.
